Please login to the form below

Not currently logged in
Email:
Password:

Trevor Aukim joins emotive as head of development

Agency's recent joiners also include LizzieNayman and Ana Mootoosamy

emotive Trevor AukimLondon-based healthcare digital and innovation agency emotive has made a raft of new appointments, among them Trevor Aukim who joins as head of development.

He has over 15 years global agency experience directing medical communications projects encompassing e-learning, health tracking applications and pharma focused online content.

Aukim spent five years as lead interactive developer for M&C Saatchi and spent time this year with Havas Worldwide and Burberry.

Also starting at emotive is Lizzie Nayman, who takes up a role as strategic group account director and joins the company from Aesop Agency, and senior medical writer Ana Mootoosamy.

Mootoosamy has over a decade of healthcare communication experience, working with agencies such as Cherry Advertising, CDM London and DDB Health.

emotive's other new starters are medical copywriter Serkan Ali, account manager Cecile Charrie and account executive Helen Moyes.

25th September 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics